English

INCARA PHARMACEUTICALS CORP

EDGAR

Quarterly report (10-Q) · filed 2003-08-14

39 filing records in this dataset, filed from 1996-07-09 to 2003-08-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

26 thousand USD

2001-09-30 · USD

Exact inputs and evidence

Revenue: 44000 USD Source
Revenue: 18000 USD Source

Operating margin

-11,446.15%

2001-09-30 · %

Exact inputs and evidence

Operating Income: -10553000 USD Source
Operating Income: -7577000 USD Source
Revenue: 44000 USD Source
Revenue: 18000 USD Source

Operating cash flow

-2.31 million USD

2001-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -10240000 USD Source
Operating Cash Flow: -7926000 USD Source

Free cash flow

-2.92 million USD

2001-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -10240000 USD Source
Operating Cash Flow: -7926000 USD Source
Capital Expenditure: 1312000 USD Source
Capital Expenditure: 703000 USD Source

Cash and cash equivalents: 21 thousand USD 2003-06-30 Source
Exact value

21000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-4.42 million USD

2002-07-01 – 2003-06-30

Exact inputs and evidence

Net income: -11302000 USD · 2001-10-01 – 2002-09-30 Source
Net income: -8789000 USD · 2001-10-01 – 2002-06-30 Source
Net income: 315000 USD · 2002-10-01 – 2002-12-31 Source
Net income: -1243000 USD · 2003-01-01 – 2003-03-31 Source
Net income: -976000 USD · 2003-04-01 – 2003-06-30 Source

Operating cash flow

-4.39 million USD

2002-07-01 – 2003-06-30

Exact inputs and evidence

Operating cash flow: -8558000 USD · 2001-10-01 – 2002-09-30 Source
Operating cash flow: -7311000 USD · 2001-10-01 – 2002-06-30 Source
Operating cash flow: -2582000 USD · 2002-10-01 – 2002-12-31 Source
Operating cash flow: -3002000 USD · 2002-10-01 – 2003-03-31 Source
Operating cash flow: -2582000 USD · 2002-10-01 – 2002-12-31 Source
Operating cash flow: -3145000 USD · 2002-10-01 – 2003-06-30 Source
Operating cash flow: -3002000 USD · 2002-10-01 – 2003-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2003-08-14.

Financial data available through: 2002-09-30.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2002-09-30
Operating income: 7 of 11 periods available· newest 2002-09-30
Net income: 9 of 11 periods available· newest 2002-09-30
Operating cash flow: 8 of 11 periods available· newest 2002-09-30
Capital expenditure: 8 of 11 periods available· newest 2002-09-30
Total assets: 5 of 11 periods available· newest 2000-09-30
Total liabilities: 5 of 11 periods available· newest 2000-09-30
Current assets: 7 of 11 periods available· newest 2002-09-30
Current liabilities: 7 of 11 periods available· newest 2002-09-30
Cash and cash equivalents: 7 of 11 periods available· newest 2002-09-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+95.5%

Prior period

USD 44,000

2000-10-01 – 2001-09-30
Current period

USD 86,000

2001-10-01 – 2002-09-30

Exact inputs and evidence

86000 − 44000 = 42000 USD

44000 USD · 2000-10-01 – 2001-09-30
Inspect prior input Prior source
86000 USD · 2001-10-01 – 2002-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · INCARA PHARMACEUTICALS CORP · 2002-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Year-over-year change in Revenue: 42000 USD Concept: fundies:Revenue Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 86000 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#4491 Input fundies:Revenue: 44000 USD (2000-10-01 to 2001-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#4491
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 10.91 million

Prior period

−USD 22.21 million

2000-10-01 – 2001-09-30
Current period

−USD 11.3 million

2001-10-01 – 2002-09-30

Exact inputs and evidence

-11302000 − -22213000 = 10911000 USD

-22213000 USD · 2000-10-01 – 2001-09-30
Inspect prior input Prior source
-11302000 USD · 2001-10-01 – 2002-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · INCARA PHARMACEUTICALS CORP · 2002-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Year-over-year change in Net income: 10911000 USD Concept: fundies:NetIncome Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -11302000 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#5903 Input fundies:NetIncome: -22213000 USD (2000-10-01 to 2001-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#5903
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 1.68 million

Prior period

−USD 10.24 million

2000-10-01 – 2001-09-30
Current period

−USD 8.56 million

2001-10-01 – 2002-09-30

Exact inputs and evidence

-8558000 − -10240000 = 1682000 USD

-10240000 USD · 2000-10-01 – 2001-09-30
Inspect prior input Prior source
-8558000 USD · 2001-10-01 – 2002-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · INCARA PHARMACEUTICALS CORP · 2002-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Year-over-year change in Operating cash flow: 1682000 USD Concept: fundies:OperatingCashFlow Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -8558000 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#6113 Input fundies:OperatingCashFlow: -10240000 USD (2000-10-01 to 2001-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#6113
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-80.2%

Prior period

USD 1.31 million

2000-10-01 – 2001-09-30
Current period

USD 260,000

2001-10-01 – 2002-09-30

Exact inputs and evidence

260000 − 1312000 = -1052000 USD

1312000 USD · 2000-10-01 – 2001-09-30
Inspect prior input Prior source
260000 USD · 2001-10-01 – 2002-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · INCARA PHARMACEUTICALS CORP · 2002-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Year-over-year change in Capital expenditure: -1052000 USD Concept: fundies:CapitalExpenditure Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 260000 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#6225 Input fundies:CapitalExpenditure: 1312000 USD (2000-10-01 to 2001-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#6225
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2002 2001-10-01 – 2002-09-30

Revenue USD 86,000 100% of revenue
Operating costs Derived USD 10.45 million 12,149% of revenue
Operating income −USD 10.36 million −12,049% of revenue
Tax, interest and other Derived USD 940,000 1,093% of revenue
Net income −USD 11.3 million −13,142% of revenue

Cash

Operating cash flow −USD 8.56 million −9,951% of revenue
Capital expenditure USD 260,000 302% of revenue
Free cash flow Derived −USD 8.82 million −10,253% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1995 Not shown: operating income or net income is not reported.
1996 Operating loss: operating costs were 158% of revenue.
1997 Operating loss: operating costs were 412% of revenue.
1999 Operating loss: operating costs were 1,056% of revenue.
2000 Operating loss: operating costs were 16,922% of revenue.
2001 Operating loss: operating costs were 24,084% of revenue.
2002 Operating loss: operating costs were 12,149% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1995 1994-10-01 – 1995-09-30	61663	Unavailable	Unavailable	Unavailable	-2524912	-2356708 Derived	Source 1994-10-01 – 1995-09-30: 61663 USD Inspect Revenue Open source 1994-10-01 – 1995-09-30: -2524912 USD Inspect Net Income Open source 1994-10-01 – 1995-09-30: -2340829 USD Inspect Operating Cash Flow Open source 1994-10-01 – 1995-09-30: 15879 USD Inspect Capital Expenditure Open source
1996 1995-10-01 – 1996-09-30	6351088	10025088 Derived	-3674000	-114000 Derived	-3560000	-2828000 Derived	Source 1995-10-01 – 1996-09-30: 6351088 USD Inspect Revenue Open source 1995-10-01 – 1996-09-30: -3674000 USD Inspect Operating Income Open source 1995-10-01 – 1996-09-30: -3560000 USD Inspect Net Income Open source 1995-10-01 – 1996-09-30: -1584000 USD Inspect Operating Cash Flow Open source 1995-10-01 – 1996-09-30: 1244000 USD Inspect Capital Expenditure Open source
1997 1996-10-01 – 1997-09-30	6153085	25355085 Derived	-19202000	-1399000 Derived	-17803000	-7375000 Derived	Source 1996-10-01 – 1997-09-30: 6153085 USD Inspect Revenue Open source 1996-10-01 – 1997-09-30: -19202000 USD Inspect Operating Income Open source 1996-10-01 – 1997-09-30: -17803000 USD Inspect Net Income Open source 1996-10-01 – 1997-09-30: -5131000 USD Inspect Operating Cash Flow Open source 1996-10-01 – 1997-09-30: 2244000 USD Inspect Capital Expenditure Open source
1999 1998-10-01 – 1999-09-30	2088000	22041000 Derived	-19953000	-355000 Derived	-19598000	-18659000 Derived	Source 1998-10-01 – 1999-09-30: 2088000 USD Inspect Revenue Open source 1998-10-01 – 1999-09-30: -19953000 USD Inspect Operating Income Open source 1998-10-01 – 1999-09-30: -19598000 USD Inspect Net Income Open source 1998-10-01 – 1999-09-30: -18381000 USD Inspect Operating Cash Flow Open source 1998-10-01 – 1999-09-30: 278000 USD Inspect Capital Expenditure Open source
2000 1999-10-01 – 2000-09-30	100000	16922000 Derived	-16822000	-10157000 Derived	-6665000	-9046000 Derived	Source 1999-10-01 – 2000-09-30: 100000 USD Inspect Revenue Open source 1999-10-01 – 2000-09-30: -16822000 USD Inspect Operating Income Open source 1999-10-01 – 2000-09-30: -6665000 USD Inspect Net Income Open source 1999-10-01 – 2000-09-30: -8932000 USD Inspect Operating Cash Flow Open source 1999-10-01 – 2000-09-30: 114000 USD Inspect Capital Expenditure Open source
2001 2000-10-01 – 2001-09-30	44000	10597000 Derived	-10553000	11660000 Derived	-22213000	-11552000 Derived	Source 2000-10-01 – 2001-09-30: 44000 USD Inspect Revenue Open source 2000-10-01 – 2001-09-30: -10553000 USD Inspect Operating Income Open source 2000-10-01 – 2001-09-30: -22213000 USD Inspect Net Income Open source 2000-10-01 – 2001-09-30: -10240000 USD Inspect Operating Cash Flow Open source 2000-10-01 – 2001-09-30: 1312000 USD Inspect Capital Expenditure Open source
2002 2001-10-01 – 2002-09-30	86000	10448000 Derived	-10362000	940000 Derived	-11302000	-8818000 Derived	Source 2001-10-01 – 2002-09-30: 86000 USD Inspect Revenue Open source 2001-10-01 – 2002-09-30: -10362000 USD Inspect Operating Income Open source 2001-10-01 – 2002-09-30: -11302000 USD Inspect Net Income Open source 2001-10-01 – 2002-09-30: -8558000 USD Inspect Operating Cash Flow Open source 2001-10-01 – 2002-09-30: 260000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 86K 2002

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-09-30	Revenue	61663	Revenue: 61663 Open source
19961996-09-30	Revenue	6351088	Revenue: 6351088 Open source
19971997-09-30	Revenue	6153085	Revenue: 6153085 Open source
19991999-09-30	Revenue	2088000	Revenue: 2088000 Open source
20002000-09-30	Revenue	100000	Revenue: 100000 Open source
20012001-09-30	Revenue	44000	Revenue: 44000 Open source
20022002-09-30	Revenue	86000	Revenue: 86000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

95.5% 2002

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19951995-09-30	Year over year	No prior comparable period	Revenue: 61663 Open source
19961996-09-30	Year over year	10,199.7%	Revenue: 6351088 Open source Revenue: 61663 Open source
19971997-09-30	Year over year	-3.1%	Revenue: 6153085 Open source Revenue: 6351088 Open source
19991999-09-30	Year over year	No prior comparable period	Revenue: 2088000 Open source
20002000-09-30	Year over year	-95.2%	Revenue: 100000 Open source Revenue: 2088000 Open source
20012001-09-30	Year over year	-56%	Revenue: 44000 Open source Revenue: 100000 Open source
20022002-09-30	Year over year	95.5%	Revenue: 86000 Open source Revenue: 44000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -12,048.8% 2002

Net margin -13,141.9% 2002

Free cash flow margin -10,253.5% 2002

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
1995-09-30	Operating margin	Not reported	Revenue: 61663 Open source
19961996-09-30	Operating margin	-57.8%	Operating Income: -3674000 Open source Revenue: 6351088 Open source
19971997-09-30	Operating margin	-312.1%	Operating Income: -19202000 Open source Revenue: 6153085 Open source
19991999-09-30	Operating margin	-955.6%	Operating Income: -19953000 Open source Revenue: 2088000 Open source
20002000-09-30	Operating margin	-16,822%	Operating Income: -16822000 Open source Revenue: 100000 Open source
20012001-09-30	Operating margin	-23,984.1%	Operating Income: -10553000 Open source Revenue: 44000 Open source
20022002-09-30	Operating margin	-12,048.8%	Operating Income: -10362000 Open source Revenue: 86000 Open source
19951995-09-30	Net margin	-4,094.7%	Net Income: -2524912 Open source Revenue: 61663 Open source
19961996-09-30	Net margin	-56.1%	Net Income: -3560000 Open source Revenue: 6351088 Open source
19971997-09-30	Net margin	-289.3%	Net Income: -17803000 Open source Revenue: 6153085 Open source
19991999-09-30	Net margin	-938.6%	Net Income: -19598000 Open source Revenue: 2088000 Open source
20002000-09-30	Net margin	-6,665%	Net Income: -6665000 Open source Revenue: 100000 Open source
20012001-09-30	Net margin	-50,484.1%	Net Income: -22213000 Open source Revenue: 44000 Open source
20022002-09-30	Net margin	-13,141.9%	Net Income: -11302000 Open source Revenue: 86000 Open source
19951995-09-30	Free cash flow margin	-3,821.9%	Revenue: 61663 Open source Operating Cash Flow: -2340829 Open source Capital Expenditure: 15879 Open source
19961996-09-30	Free cash flow margin	-44.5%	Revenue: 6351088 Open source Operating Cash Flow: -1584000 Open source Capital Expenditure: 1244000 Open source
19971997-09-30	Free cash flow margin	-119.9%	Revenue: 6153085 Open source Operating Cash Flow: -5131000 Open source Capital Expenditure: 2244000 Open source
19991999-09-30	Free cash flow margin	-893.6%	Revenue: 2088000 Open source Operating Cash Flow: -18381000 Open source Capital Expenditure: 278000 Open source
20002000-09-30	Free cash flow margin	-9,046%	Revenue: 100000 Open source Operating Cash Flow: -8932000 Open source Capital Expenditure: 114000 Open source
20012001-09-30	Free cash flow margin	-26,254.5%	Revenue: 44000 Open source Operating Cash Flow: -10240000 Open source Capital Expenditure: 1312000 Open source
20022002-09-30	Free cash flow margin	-10,253.5%	Revenue: 86000 Open source Operating Cash Flow: -8558000 Open source Capital Expenditure: 260000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -8.6M 2002

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-09-30	Operating cash flow	-2340829	Operating Cash Flow: -2340829 Open source
19961996-09-30	Operating cash flow	-1584000	Operating Cash Flow: -1584000 Open source
19971997-09-30	Operating cash flow	-5131000	Operating Cash Flow: -5131000 Open source
19991999-09-30	Operating cash flow	-18381000	Operating Cash Flow: -18381000 Open source
20002000-09-30	Operating cash flow	-8932000	Operating Cash Flow: -8932000 Open source
20012001-09-30	Operating cash flow	-10240000	Operating Cash Flow: -10240000 Open source
20022002-09-30	Operating cash flow	-8558000	Operating Cash Flow: -8558000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -8.8M 2002

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-09-30	Free cash flow	-2356708	Operating Cash Flow: -2340829 Open source Capital Expenditure: 15879 Open source
19961996-09-30	Free cash flow	-2828000	Operating Cash Flow: -1584000 Open source Capital Expenditure: 1244000 Open source
19971997-09-30	Free cash flow	-7375000	Operating Cash Flow: -5131000 Open source Capital Expenditure: 2244000 Open source
19991999-09-30	Free cash flow	-18659000	Operating Cash Flow: -18381000 Open source Capital Expenditure: 278000 Open source
20002000-09-30	Free cash flow	-9046000	Operating Cash Flow: -8932000 Open source Capital Expenditure: 114000 Open source
20012001-09-30	Free cash flow	-11552000	Operating Cash Flow: -10240000 Open source Capital Expenditure: 1312000 Open source
20022002-09-30	Free cash flow	-8818000	Operating Cash Flow: -8558000 Open source Capital Expenditure: 260000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

34.5% 2000

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
19951995-09-30	Liabilities / assets	165.3%	Total Liabilities: 3463000 Open source Total Assets: 2095000 Open source
19961996-09-30	Liabilities / assets	23.1%	Total Liabilities: 9401000 Open source Total Assets: 40650000 Open source
19971997-09-30	Liabilities / assets	68.4%	Total Liabilities: 29167000 Open source Total Assets: 42623000 Open source
19991999-09-30	Liabilities / assets	52.9%	Total Liabilities: 4253000 Open source Total Assets: 8044000 Open source
20002000-09-30	Liabilities / assets	34.5%	Total Liabilities: 2536000 Open source Total Assets: 7348000 Open source
2001-09-30	Liabilities / assets	Not reported	No source recorded
2002-09-30	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

0.27× 2002

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19951995-09-30	Current assets / current liabilities	0.87×	Current Assets: 1130142 Open source Current Liabilities: 1306300 Open source
19961996-09-30	Current assets / current liabilities	18.25×	Current Assets: 37067202 Open source Current Liabilities: 2031350 Open source
19971997-09-30	Current assets / current liabilities	1.36×	Current Assets: 36894000 Open source Current Liabilities: 27039000 Open source
19991999-09-30	Current assets / current liabilities	1.67×	Current Assets: 5479000 Open source Current Liabilities: 3272000 Open source
20002000-09-30	Current assets / current liabilities	2.87×	Current Assets: 7155000 Open source Current Liabilities: 2493000 Open source
20012001-09-30	Current assets / current liabilities	2.34×	Current Assets: 6921000 Open source Current Liabilities: 2954000 Open source
20022002-09-30	Current assets / current liabilities	0.27×	Current Assets: 593000 Open source Current Liabilities: 2183000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1993-10-01 – 1994-09-30	−USD 1.96 million Exact value Exact value: -1958344 USD 1993-10-01 – 1994-09-30: -1958344 USD Inspect Net Income Open source Share or cite Citation for Net Income · INCARA PHARMACEUTICALS CORP · 1994-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Net Income: -1958344 USD Concept: fundies:NetIncome Period: 1993-10-01 to 1994-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3ANetIncome&period=1994-09-30&surface=latest&period_type=duration&start=1993-10-01&unit=USD&dimensions= Input fundies:NetIncome: -1958344 USD (1993-10-01 to 1994-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950168-96-002471.txt#2297 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
1995 1994-10-01 – 1995-09-30	−USD 2.52 million Exact value Exact value: -2524912 USD 1994-10-01 – 1995-09-30: -2524912 USD Inspect Net Income Open source Share or cite Citation for Net Income · INCARA PHARMACEUTICALS CORP · 1995-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Net Income: -2524912 USD Concept: fundies:NetIncome Period: 1994-10-01 to 1995-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3ANetIncome&period=1995-09-30&surface=latest&period_type=duration&start=1994-10-01&unit=USD&dimensions= Input fundies:NetIncome: -2524912 USD (1994-10-01 to 1995-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950168-97-003662.txt#2605 The citation records this snapshot. The page link may show a newer release later.	−USD 2.34 million Exact value Exact value: -2340829 USD 1994-10-01 – 1995-09-30: -2340829 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INCARA PHARMACEUTICALS CORP · 1995-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Operating Cash Flow: -2340829 USD Concept: fundies:OperatingCashFlow Period: 1994-10-01 to 1995-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3AOperatingCashFlow&period=1995-09-30&surface=latest&period_type=duration&start=1994-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2340829 USD (1994-10-01 to 1995-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950168-97-003662.txt#2617 The citation records this snapshot. The page link may show a newer release later.	USD 15,879 Exact value Exact value: 15879 USD 1994-10-01 – 1995-09-30: 15879 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INCARA PHARMACEUTICALS CORP · 1995-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Capital Expenditure: 15879 USD Concept: fundies:CapitalExpenditure Period: 1994-10-01 to 1995-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3ACapitalExpenditure&period=1995-09-30&surface=latest&period_type=duration&start=1994-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 15879 USD (1994-10-01 to 1995-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950168-97-003662.txt#2624 The citation records this snapshot. The page link may show a newer release later.	−USD 2.36 million Calculation and evidence -2340829 − 15879 USD Exact free cash flow: -2356708 USD 1994-10-01 – 1995-09-30: -2340829 USD · Inspect Operating Cash Flow · Source 1994-10-01 – 1995-09-30: 15879 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INCARA PHARMACEUTICALS CORP · 1995-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Free cash flow: -2356708 USD Concept: free-cash-flow Period: 1994-10-01 to 1995-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2340829 USD (1994-10-01 to 1995-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950168-97-003662.txt#2617 Input fundies:CapitalExpenditure: 15879 USD (1994-10-01 to 1995-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950168-97-003662.txt#2624 The citation records this snapshot. The page link may show a newer release later.
1996 1995-10-01 – 1996-09-30	−USD 3.56 million Exact value Exact value: -3560000 USD 1995-10-01 – 1996-09-30: -3560000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INCARA PHARMACEUTICALS CORP · 1996-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Net Income: -3560000 USD Concept: fundies:NetIncome Period: 1995-10-01 to 1996-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3ANetIncome&period=1996-09-30&surface=latest&period_type=duration&start=1995-10-01&unit=USD&dimensions= Input fundies:NetIncome: -3560000 USD (1995-10-01 to 1996-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950168-98-003865.txt#3613 The citation records this snapshot. The page link may show a newer release later.	−USD 1.58 million Exact value Exact value: -1584000 USD 1995-10-01 – 1996-09-30: -1584000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INCARA PHARMACEUTICALS CORP · 1996-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Operating Cash Flow: -1584000 USD Concept: fundies:OperatingCashFlow Period: 1995-10-01 to 1996-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3AOperatingCashFlow&period=1996-09-30&surface=latest&period_type=duration&start=1995-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1584000 USD (1995-10-01 to 1996-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950168-98-003865.txt#3627 The citation records this snapshot. The page link may show a newer release later.	USD 1.24 million Exact value Exact value: 1244000 USD 1995-10-01 – 1996-09-30: 1244000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INCARA PHARMACEUTICALS CORP · 1996-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Capital Expenditure: 1244000 USD Concept: fundies:CapitalExpenditure Period: 1995-10-01 to 1996-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3ACapitalExpenditure&period=1996-09-30&surface=latest&period_type=duration&start=1995-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1244000 USD (1995-10-01 to 1996-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950168-98-003865.txt#3632 The citation records this snapshot. The page link may show a newer release later.	−USD 2.83 million Calculation and evidence -1584000 − 1244000 USD Exact free cash flow: -2828000 USD 1995-10-01 – 1996-09-30: -1584000 USD · Inspect Operating Cash Flow · Source 1995-10-01 – 1996-09-30: 1244000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INCARA PHARMACEUTICALS CORP · 1996-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Free cash flow: -2828000 USD Concept: free-cash-flow Period: 1995-10-01 to 1996-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1584000 USD (1995-10-01 to 1996-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950168-98-003865.txt#3627 Input fundies:CapitalExpenditure: 1244000 USD (1995-10-01 to 1996-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950168-98-003865.txt#3632 The citation records this snapshot. The page link may show a newer release later.
1997 1996-10-01 – 1997-09-30	−USD 17.8 million Exact value Exact value: -17803000 USD 1996-10-01 – 1997-09-30: -17803000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INCARA PHARMACEUTICALS CORP · 1997-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Net Income: -17803000 USD Concept: fundies:NetIncome Period: 1996-10-01 to 1997-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3ANetIncome&period=1997-09-30&surface=latest&period_type=duration&start=1996-10-01&unit=USD&dimensions= Input fundies:NetIncome: -17803000 USD (1996-10-01 to 1997-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950168-00-000018.txt#2451 The citation records this snapshot. The page link may show a newer release later.	−USD 5.13 million Exact value Exact value: -5131000 USD 1996-10-01 – 1997-09-30: -5131000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INCARA PHARMACEUTICALS CORP · 1997-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Operating Cash Flow: -5131000 USD Concept: fundies:OperatingCashFlow Period: 1996-10-01 to 1997-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3AOperatingCashFlow&period=1997-09-30&surface=latest&period_type=duration&start=1996-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5131000 USD (1996-10-01 to 1997-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950168-00-000018.txt#2465 The citation records this snapshot. The page link may show a newer release later.	USD 2.24 million Exact value Exact value: 2244000 USD 1996-10-01 – 1997-09-30: 2244000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INCARA PHARMACEUTICALS CORP · 1997-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Capital Expenditure: 2244000 USD Concept: fundies:CapitalExpenditure Period: 1996-10-01 to 1997-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3ACapitalExpenditure&period=1997-09-30&surface=latest&period_type=duration&start=1996-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2244000 USD (1996-10-01 to 1997-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950168-00-000018.txt#2470 The citation records this snapshot. The page link may show a newer release later.	−USD 7.38 million Calculation and evidence -5131000 − 2244000 USD Exact free cash flow: -7375000 USD 1996-10-01 – 1997-09-30: -5131000 USD · Inspect Operating Cash Flow · Source 1996-10-01 – 1997-09-30: 2244000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INCARA PHARMACEUTICALS CORP · 1997-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Free cash flow: -7375000 USD Concept: free-cash-flow Period: 1996-10-01 to 1997-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5131000 USD (1996-10-01 to 1997-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950168-00-000018.txt#2465 Input fundies:CapitalExpenditure: 2244000 USD (1996-10-01 to 1997-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950168-00-000018.txt#2470 The citation records this snapshot. The page link may show a newer release later.
1998 1997-10-01 – 1998-09-30	−USD 19.15 million Exact value Exact value: -19146000 USD 1997-10-01 – 1998-09-30: -19146000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INCARA PHARMACEUTICALS CORP · 1998-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Net Income: -19146000 USD Concept: fundies:NetIncome Period: 1997-10-01 to 1998-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3ANetIncome&period=1998-09-30&surface=latest&period_type=duration&start=1997-10-01&unit=USD&dimensions= Input fundies:NetIncome: -19146000 USD (1997-10-01 to 1998-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001021408-01-504256.txt#635 The citation records this snapshot. The page link may show a newer release later.	−USD 20.33 million Exact value Exact value: -20326000 USD 1997-10-01 – 1998-09-30: -20326000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INCARA PHARMACEUTICALS CORP · 1998-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Operating Cash Flow: -20326000 USD Concept: fundies:OperatingCashFlow Period: 1997-10-01 to 1998-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3AOperatingCashFlow&period=1998-09-30&surface=latest&period_type=duration&start=1997-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20326000 USD (1997-10-01 to 1998-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001021408-01-504256.txt#651 The citation records this snapshot. The page link may show a newer release later.	USD 1.11 million Exact value Exact value: 1110000 USD 1997-10-01 – 1998-09-30: 1110000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INCARA PHARMACEUTICALS CORP · 1998-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Capital Expenditure: 1110000 USD Concept: fundies:CapitalExpenditure Period: 1997-10-01 to 1998-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3ACapitalExpenditure&period=1998-09-30&surface=latest&period_type=duration&start=1997-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1110000 USD (1997-10-01 to 1998-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001021408-01-504256.txt#658 The citation records this snapshot. The page link may show a newer release later.	−USD 21.44 million Calculation and evidence -20326000 − 1110000 USD Exact free cash flow: -21436000 USD 1997-10-01 – 1998-09-30: -20326000 USD · Inspect Operating Cash Flow · Source 1997-10-01 – 1998-09-30: 1110000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INCARA PHARMACEUTICALS CORP · 1998-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Free cash flow: -21436000 USD Concept: free-cash-flow Period: 1997-10-01 to 1998-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20326000 USD (1997-10-01 to 1998-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001021408-01-504256.txt#651 Input fundies:CapitalExpenditure: 1110000 USD (1997-10-01 to 1998-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001021408-01-504256.txt#658 The citation records this snapshot. The page link may show a newer release later.
1999 1998-10-01 – 1999-09-30	−USD 19.6 million Exact value Exact value: -19598000 USD 1998-10-01 – 1999-09-30: -19598000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INCARA PHARMACEUTICALS CORP · 1999-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Net Income: -19598000 USD Concept: fundies:NetIncome Period: 1998-10-01 to 1999-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3ANetIncome&period=1999-09-30&surface=latest&period_type=duration&start=1998-10-01&unit=USD&dimensions= Input fundies:NetIncome: -19598000 USD (1998-10-01 to 1999-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950109-02-004130.txt#3882 The citation records this snapshot. The page link may show a newer release later.	−USD 18.38 million Exact value Exact value: -18381000 USD 1998-10-01 – 1999-09-30: -18381000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INCARA PHARMACEUTICALS CORP · 1999-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Operating Cash Flow: -18381000 USD Concept: fundies:OperatingCashFlow Period: 1998-10-01 to 1999-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3AOperatingCashFlow&period=1999-09-30&surface=latest&period_type=duration&start=1998-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18381000 USD (1998-10-01 to 1999-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950109-02-004130.txt#4092 The citation records this snapshot. The page link may show a newer release later.	USD 278,000 Exact value Exact value: 278000 USD 1998-10-01 – 1999-09-30: 278000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INCARA PHARMACEUTICALS CORP · 1999-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Capital Expenditure: 278000 USD Concept: fundies:CapitalExpenditure Period: 1998-10-01 to 1999-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3ACapitalExpenditure&period=1999-09-30&surface=latest&period_type=duration&start=1998-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 278000 USD (1998-10-01 to 1999-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950109-02-004130.txt#4176 The citation records this snapshot. The page link may show a newer release later.	−USD 18.66 million Calculation and evidence -18381000 − 278000 USD Exact free cash flow: -18659000 USD 1998-10-01 – 1999-09-30: -18381000 USD · Inspect Operating Cash Flow · Source 1998-10-01 – 1999-09-30: 278000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INCARA PHARMACEUTICALS CORP · 1999-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Free cash flow: -18659000 USD Concept: free-cash-flow Period: 1998-10-01 to 1999-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18381000 USD (1998-10-01 to 1999-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950109-02-004130.txt#4092 Input fundies:CapitalExpenditure: 278000 USD (1998-10-01 to 1999-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0000950109-02-004130.txt#4176 The citation records this snapshot. The page link may show a newer release later.
2000 1999-10-01 – 2000-09-30	−USD 6.67 million Exact value Exact value: -6665000 USD 1999-10-01 – 2000-09-30: -6665000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INCARA PHARMACEUTICALS CORP · 2000-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Net Income: -6665000 USD Concept: fundies:NetIncome Period: 1999-10-01 to 2000-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3ANetIncome&period=2000-09-30&surface=latest&period_type=duration&start=1999-10-01&unit=USD&dimensions= Input fundies:NetIncome: -6665000 USD (1999-10-01 to 2000-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#5903 The citation records this snapshot. The page link may show a newer release later.	−USD 8.93 million Exact value Exact value: -8932000 USD 1999-10-01 – 2000-09-30: -8932000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INCARA PHARMACEUTICALS CORP · 2000-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Operating Cash Flow: -8932000 USD Concept: fundies:OperatingCashFlow Period: 1999-10-01 to 2000-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3AOperatingCashFlow&period=2000-09-30&surface=latest&period_type=duration&start=1999-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8932000 USD (1999-10-01 to 2000-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#6113 The citation records this snapshot. The page link may show a newer release later.	USD 114,000 Exact value Exact value: 114000 USD 1999-10-01 – 2000-09-30: 114000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INCARA PHARMACEUTICALS CORP · 2000-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Capital Expenditure: 114000 USD Concept: fundies:CapitalExpenditure Period: 1999-10-01 to 2000-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3ACapitalExpenditure&period=2000-09-30&surface=latest&period_type=duration&start=1999-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 114000 USD (1999-10-01 to 2000-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#6225 The citation records this snapshot. The page link may show a newer release later.	−USD 9.05 million Calculation and evidence -8932000 − 114000 USD Exact free cash flow: -9046000 USD 1999-10-01 – 2000-09-30: -8932000 USD · Inspect Operating Cash Flow · Source 1999-10-01 – 2000-09-30: 114000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INCARA PHARMACEUTICALS CORP · 2000-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Free cash flow: -9046000 USD Concept: free-cash-flow Period: 1999-10-01 to 2000-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8932000 USD (1999-10-01 to 2000-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#6113 Input fundies:CapitalExpenditure: 114000 USD (1999-10-01 to 2000-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#6225 The citation records this snapshot. The page link may show a newer release later.
2001 2000-10-01 – 2001-09-30	−USD 22.21 million Exact value Exact value: -22213000 USD 2000-10-01 – 2001-09-30: -22213000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INCARA PHARMACEUTICALS CORP · 2001-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Net Income: -22213000 USD Concept: fundies:NetIncome Period: 2000-10-01 to 2001-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3ANetIncome&period=2001-09-30&surface=latest&period_type=duration&start=2000-10-01&unit=USD&dimensions= Input fundies:NetIncome: -22213000 USD (2000-10-01 to 2001-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#5903 The citation records this snapshot. The page link may show a newer release later.	−USD 10.24 million Exact value Exact value: -10240000 USD 2000-10-01 – 2001-09-30: -10240000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INCARA PHARMACEUTICALS CORP · 2001-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Operating Cash Flow: -10240000 USD Concept: fundies:OperatingCashFlow Period: 2000-10-01 to 2001-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3AOperatingCashFlow&period=2001-09-30&surface=latest&period_type=duration&start=2000-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10240000 USD (2000-10-01 to 2001-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#6113 The citation records this snapshot. The page link may show a newer release later.	USD 1.31 million Exact value Exact value: 1312000 USD 2000-10-01 – 2001-09-30: 1312000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INCARA PHARMACEUTICALS CORP · 2001-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Capital Expenditure: 1312000 USD Concept: fundies:CapitalExpenditure Period: 2000-10-01 to 2001-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3ACapitalExpenditure&period=2001-09-30&surface=latest&period_type=duration&start=2000-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1312000 USD (2000-10-01 to 2001-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#6225 The citation records this snapshot. The page link may show a newer release later.	−USD 11.55 million Calculation and evidence -10240000 − 1312000 USD Exact free cash flow: -11552000 USD 2000-10-01 – 2001-09-30: -10240000 USD · Inspect Operating Cash Flow · Source 2000-10-01 – 2001-09-30: 1312000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INCARA PHARMACEUTICALS CORP · 2001-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Free cash flow: -11552000 USD Concept: free-cash-flow Period: 2000-10-01 to 2001-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10240000 USD (2000-10-01 to 2001-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#6113 Input fundies:CapitalExpenditure: 1312000 USD (2000-10-01 to 2001-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#6225 The citation records this snapshot. The page link may show a newer release later.
2002 2001-10-01 – 2002-09-30	−USD 11.3 million Exact value Exact value: -11302000 USD 2001-10-01 – 2002-09-30: -11302000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INCARA PHARMACEUTICALS CORP · 2002-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Net Income: -11302000 USD Concept: fundies:NetIncome Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3ANetIncome&period=2002-09-30&surface=latest&period_type=duration&start=2001-10-01&unit=USD&dimensions= Input fundies:NetIncome: -11302000 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#5903 The citation records this snapshot. The page link may show a newer release later.	−USD 8.56 million Exact value Exact value: -8558000 USD 2001-10-01 – 2002-09-30: -8558000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INCARA PHARMACEUTICALS CORP · 2002-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Operating Cash Flow: -8558000 USD Concept: fundies:OperatingCashFlow Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3AOperatingCashFlow&period=2002-09-30&surface=latest&period_type=duration&start=2001-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8558000 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#6113 The citation records this snapshot. The page link may show a newer release later.	USD 260,000 Exact value Exact value: 260000 USD 2001-10-01 – 2002-09-30: 260000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INCARA PHARMACEUTICALS CORP · 2002-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Capital Expenditure: 260000 USD Concept: fundies:CapitalExpenditure Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538/explain?concept=fundies%3ACapitalExpenditure&period=2002-09-30&surface=latest&period_type=duration&start=2001-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 260000 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#6225 The citation records this snapshot. The page link may show a newer release later.	−USD 8.82 million Calculation and evidence -8558000 − 260000 USD Exact free cash flow: -8818000 USD 2001-10-01 – 2002-09-30: -8558000 USD · Inspect Operating Cash Flow · Source 2001-10-01 – 2002-09-30: 260000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INCARA PHARMACEUTICALS CORP · 2002-09-30 INCARA PHARMACEUTICALS CORP (edgar:936538) Free cash flow: -8818000 USD Concept: free-cash-flow Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/936538?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8558000 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#6113 Input fundies:CapitalExpenditure: 260000 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/936538/0001012870-02-004739.txt#6225 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

39 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000936538, 936538, edgar:936538

Also known as INTERCARDIA INC

INCARA PHARMACEUTICALS CORP

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2002 2001-10-01 – 2002-09-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation